Latest article
Novo Nordisk to launch GLP-1 injectible diabetes drug in pill type by February
Novo Nordisk, headquartered in Denmark and a leader in the diabetes market, plans to launch this oral GLP-1 drug in India by February 2022....
May Combos Substitute Basal-Bolus Insulin in Kind 2 Diabetes?
For patients with type 2 diabetes who receive multiple daily insulin injections, switching to combination treatment with basal...
/cloudfront-us-east-1.images.arcpublishing.com/gray/SCQEU6RPQJBJFC53XGATFO65BI.jpg "New transfusion expertise helps stop diabetes"){kind=small}
New transfusion expertise helps stop diabetes
CLEVELAND, Ohio (Ivanhoe Newswire) - Pancreatitis, a painful inflammation of the pancreas, is sometimes associated in the elderly. But there is another form...